Susquehanna International Group’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,406
| Closed | -$13K | – | 13772 |
|
|
2023
Q3 | $13K | Buy |
+10,406
| New | +$12.5K | ﹤0.01% | 11691 |
|
|
2023
Q2 | – | Sell |
-749
| Closed | -$7.64K | – | 13675 |
|
|
2023
Q1 | $7.64K | Buy |
749
+344
| +85% | +$4.98K | ﹤0.01% | 12247 |
|
|
2022
Q4 | $6.44K | Sell |
405
-252
| -38% | -$5.56K | ﹤0.01% | 12010 |
|
|
2022
Q3 | $18K | Buy |
+657
| New | +$19.4K | ﹤0.01% | 12646 |
|
|
2022
Q1 | – | Sell |
-951
| Closed | -$74.7K | – | 14346 |
|
|
2021
Q4 | $103K | Buy |
951
+421
| +79% | +$48.5K | ﹤0.01% | 12132 |
|
|
2021
Q3 | $64K | Buy |
530
+183
| +53% | +$21.4K | ﹤0.01% | 12266 |
|
|
2021
Q2 | $44K | Sell |
347
-1,986
| -85% | -$269K | ﹤0.01% | 12330 |
|
|
2021
Q1 | $356K | Buy |
+2,333
| New | +$424K | ﹤0.01% | 10247 |
|
|
2020
Q2 | – | Sell |
-118
| Closed | -$9K | – | 11199 |
|
|
2020
Q1 | $9K | Buy |
+118
| New | +$12.1K | ﹤0.01% | 10061 |
|
|
2019
Q4 | – | Sell |
-55
| Closed | -$13K | – | 10925 |
|
|
2019
Q3 | $13K | Buy |
+55
| New | +$15.8K | ﹤0.01% | 9994 |
|
|
2019
Q2 | – | Sell |
-93
| Closed | -$32K | – | 11032 |
|
|
2019
Q1 | $32K | Buy |
+93
| New | +$37.7K | ﹤0.01% | 8545 |
|
|
2018
Q2 | – | Sell |
-5
| Closed | -$13K | – | 10660 |
|
|
2018
Q1 | $13K | Sell |
5
-147
| -97% | -$552K | ﹤0.01% | 9173 |
|
|
2017
Q4 | $949K | Buy |
+152
| New | +$1.2M | ﹤0.01% | 5342 |
|
|
2017
Q2 | – | Sell |
-89
| Closed | -$1.26M | – | 10020 |
|
|
2017
Q1 | $1.7M | Buy |
+89
| New | +$1.51M | ﹤0.01% | 4020 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$20K | – | 9862 |
|
|
2015
Q4 | $20K | Hold |
1
| – | – | ﹤0.01% | 9231 |
|
|
2015
Q3 | $42K | Buy |
+1
| New | +$62.5K | ﹤0.01% | 9400 |
|
Susquehanna International Group's BIOC Position: Q4 2023 in Review
Susquehanna International Group sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 10,406 shares — an estimated $13K sold.
Susquehanna International Group first reported a position in BIOC in Q3 2015 and held it in 16 quarters. The position peaked at $1.7M in Q1 2017. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.
- Susquehanna International Group reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
- Susquehanna International Group sold 10,406 Biocept, Inc. shares in Q4 2023, an estimated $13K.
- Susquehanna International Group first reported a position in Biocept, Inc. in Q3 2015 and held it in 16 quarters.
- Susquehanna International Group's Biocept, Inc. position peaked at $1.7M in Q1 2017.
- 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.